Skip to main content

Table 2 Therapy regime and treatment duration

From: Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort

 

GT 1

GT 2

GT 3

GT 4

SOF + PEG + RBV

    

 12 weeks

43 % (51)

0

12 % (14)

3 % (4)

 24 weeks

10 % (12)

0

0

0

SOF + RBV

    

 12 weeks

0

12 % (14)

0

0

 24 weeks

11 % (13)

0

8 % (10)

1 % (1)

  1. Data are expressed as percent (number)
  2. GT genotype, SOF sofosbuvir, PEG pegylated-interferon, RBV ribavirin